Pharmacy Times

Oncology Pharmacists Connect was more than just learning the latest breakthroughs in oncology pharmacy. This conference was designed to cultivate a community where attendees are encouraged to share perspectives from their daily practice and gain new insights into patient care. Virginia, our talented visual illustrator, showcased her remarkable ability to flawlessly capture seven sessions in real-time through her visual perspective. These captivating visuals brought each discussion to life, resonating with both attendees and faculty. Did you miss out on seeing each completed illustration? Keep an eye on your inbox—Pharmacy Times Continuing Education™ (PTCE) will be sharing these detailed illustrations soon! But first, we want to know: Which session illustration was your favorite? #OncologyPharmacistsConnect #OPC2024 #OncologyPharmacy #ContinuingEducation #Oncology #pharmacy

What an insightful discussion we had in Columbus at last nights Clinical Forum on Bispecific Therapy for Multiple Myeloma! Are you looking to participate in a Clinical Forum discussion? Learn more about upcoming dates in your area here: https://lnkd.in/g5_6cQcq

In our newest Insights series, “Empowering Pharmacists: Enhancing RSV Knowledge and Vaccine Advocacy.” Carrie Koenigsfeld, PharmD, FAPhA, sat down with Pharmacy Times® to discuss the most up-to-date vaccination trials, safety measures in older adults and pregnant women, and top communication practices for hesitant patients. Stay prepared for the peak season – stream the episodes here: https://bit.ly/3Lj1xya. #RSV #PharmacyTimes #Pharmacy

The Federal Trade Commission (FTC) has released an interim report analyzing the prescription drug middleman industry, emphasizing the outsized impact pharmacy benefit managers (PBMs) have on the pharmaceutical industry, negatively affecting patient affordability and accessibility of prescription drugs. Learn more: https://bit.ly/4cXyLiB

#FDA News: The FDA has granted fast track designation to ADI-270, a potential treatment for metastatic/advanced clear cell renal cell carcinoma. Learn more: https://ow.ly/SIC350SxaCZ

#FDA News: The FDA has approved faricimab-svoa (Vabysmo; Genetech) in a 6.0 mg single-dose prefilled syringe for the treatment of wet AMD, diabetic macular edema, and macular edema following retinal vein occlusion. Learn more: https://ow.ly/unqn50Sxaxk

A cardiac surgery system (CellFX nsPFA; Pulse Biosciences, Inc) in combination with the bipolar clamp received breakthrough device designation from the FDA for the ablation of cardiac tissue in treatment of patients with atrial fibrillation (AF). Learn more: https://bit.ly/4cQQI2i

Happy Independence Day from all of us at Pharmacy Times®! Thank you for your dedication to ensuring the well-being of our nation. We wish you a day filled with endless celebration and happiness. 🎇🤍 #Pharmacy #4thofJuly #IndependenceDay

The FDA has granted marketing authorization for Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used as a point-of-care option for patients to test for HCV. The test can detect HCV RNS and deliver results in approximately 1 hour from a blood sample. Learn more: https://bit.ly/4bu51Zm

With shrinking reimbursement, increasing fees, the threat of closure and more, the US community pharmacies are facing major challenges. However, as artificial intelligence (AI) develops, there are new opportunities for pharmacies – particularly when it comes to a cash pricing strategy. Learn more: https://bit.ly/3VQEjo8